FTO is a relevant factor for the development of the metabolic syndrome in mice

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Ikels, Kathrin ^a   Kuschel, Stefanie ^a   Fischer, Julia ^a   Kaisers, Wolfgang ^a   Eberhard, Daniel ^a   Rüther, Ulrich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LEPTIN; FTO PROTEIN, MOUSE; LYASE; MIXED FUNCTION OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FAT MASS AND OBESITY ASSOCIATED GENE; FEMALE; GENE; GENE FUNCTION; GLUCOSE TOLERANCE; HYPERGLYCEMIA; LIPID STORAGE; MALE; METABOLIC SYNDROME X; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; RISK FACTOR; WILD TYPE; ADIPOSE TISSUE; ANIMAL; BODY WEIGHT; DEFICIENCY; DISEASE MODEL; FATTY LIVER; GENETIC PREDISPOSITION; GENETICS; KNOCKOUT MOUSE; LIPID METABOLISM; LIVER CELL; METABOLISM; PANCREAS ISLET; PATHOLOGY;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; FATTY LIVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTES; HYPERGLYCEMIA; ISLETS OF LANGERHANS; LEPTIN; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MICE; MICE, KNOCKOUT; MIXED FUNCTION OXYGENASES; OXO-ACID-LYASES;

EID: 84930447908     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105349     Document Type: Article

References (46)

1. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, et al. (2000) Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102: 179-184. (Pubitemid 30451774)
2. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, et al. (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53: 2087-2094. (Pubitemid 38970759)
3. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, et al. (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163: 427-436. (Pubitemid 36241019)
4. van Herpen NA, Schrauwen-Hinderling VB (2008) Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 94: 231-241. (Pubitemid 351615422)
5. Szendroedi J, Roden M (2009) Ectopic lipids and organ function. Curr Opin Lipidol 20: 50-56.
6. Hauner H (2004) The new concept of adipose tissue function. Physiol Behav 83: 653-658.
7. Pollex RL, Hegele RA (2006) Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med 3: 482-489. (Pubitemid 44288461)
8. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, et al. (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350: 2362-2374. (Pubitemid 38702847)
9. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, et al. (1995) Transient increase in obese gene expression after food intake or insulin administration. Nature 377: 527-529.
10. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, et al. (1995) Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 95: 2986-2988.
11. Mizuno TM, Mobbs CV (1999) Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140: 814-817. (Pubitemid 29058217)
12. Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB (1997) Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 138: 839-842. (Pubitemid 27110941)
13. Balthasar N, Coppari R, McMinn J, Liu SM, Lee CE, et al. (2004) Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42: 983-991. (Pubitemid 38798236)
14. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, et al. (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387: 903-908. (Pubitemid 27289591)
15. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD (1998) A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18: 213-215.
16. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, et al. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110: 1093-1103. (Pubitemid 35215890)
17. Licinio J, Caglayan S, Ozata M, Yildiz BO, de Miranda PB, et al. (2004) Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A 101: 4531-4536. (Pubitemid 38437445)
18. Lindström P (2007) The physiology of obese-hyperglycemic mice [ob/ob mice]. ScientificWorldJournal 7: 666-685.
19. Gat-Yablonski G, Ben-Ari T, Shtaif B, Potievsky O, Moran O, et al. (2004) Leptin reverses the inhibitory effect of caloric restriction on longitudinal growth. Endocrinology 145: 343-350. (Pubitemid 38094529)
20. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, et al. (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546.
21. Lalonde J, Samson P, Poulin S, Deshaies Y, Richard D (2004) Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice. Physiol Behav 80: 415-420. (Pubitemid 38117016)
22. Doshi M, Takiue Y, Saito H, Hosoyamada M (2011) The increased protein level of URAT1 was observed in obesity/metabolic syndrome model mice. Nucleosides Nucleotides Nucleic Acids 30: 1290-1294.
23. Matsusue K, Kusakabe T, Noguchi T, Takiguchi S, Suzuki T, et al. (2008) Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab 7: 302-311. (Pubitemid 351455219)
24. Naveilhan P, Svensson L, Nystrom S, Ekstrand AJ, Ernfors P (2002) Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation. Peptides 23: 1087-1091. (Pubitemid 34786296)
25. Lee YS, Cha BY, Saito K, Yamakawa H, Choi SS, et al. (2010) Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. Biochem Pharmacol 79: 1674-1683.
26. Tabbi-Anneni I, Buchanan J, Cooksey RC, Abel ED (2008) Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts. Endocrinology 149: 4043-4050.
27. Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, et al. (2007) PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3: e64.
28. Loos RJ (2012) Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab 26: 211-226.
29. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889-894. (Pubitemid 46764279)
30. Do R, Bailey SD, Desbiens K, Belisle A, Montpetit A, et al. (2008) Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study. Diabetes 57: 1147-1150.
31. Legry V, Cottel D, Ferrieres J, Arveiler D, Andrieux N, et al. (2009) Effect of an FTO polymorphism on fat mass, obesity, and type 2 diabetes mellitus in the French MONICA Study. Metabolism 58: 971-975.
32. Haupt A, Thamer C, Staiger H, Tschritter O, Kirchhoff K, et al. (2009) Variation in the FTO gene influences food intake but not energy expenditure. Exp Clin Endocrinol Diabetes 117: 194-197.
33. Wang P, Yang FJ, Du H, Guan YF, Xu TY, et al. (2011) Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction. Mol Med 17: 523-532.
34. Stratigopoulos G, LeDuc CA, Cremona ML, Chung WK, Leibel RL (2011) Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J Biol Chem 286: 2155-2170.
35. McMurray F, Church CD, Larder R, Nicholson G, Wells S, et al. (2013) Adult onset global loss of the fto gene alters body composition and metabolism in the mouse. PLoS Genet 9: e1003166.
36. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, et al. (2009) Inactivation of the Fto gene protects from obesity. Nature 458: 894-898.
37. Tews D, Fischer-Posovszky P, Fromme T, Klingenspor M, Fischer J, et al. (2013) FTO deficiency induces UCP-1 expression and mitochondrial uncoupling in adipocytes. Endocrinology 154: 3141-3151.
38. Gao X, Shin YH, Li M, Wang F, Tong Q, et al. (2010) The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice. PLoS One 5: e14005.
39. R Core Team (2014) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available: http://www.r-project.org/.
40. Morton GJ, Matsen ME, Bracy DP, Meek TH, Nguyen HT, et al. (2013) FGF19 action in the brain induces insulin-independent glucose lowering. J Clin Invest [Epub ahead of print].
41. Lehrke M, Lazar MA (2005) The many faces of PPARgamma. Cell 123: 993-999.
42. de Luis DA, Aller R, Conde R, Izaola O, de la Fuente B, et al. (2013) Relation of the rs9939609 gene variant in FTO with metabolic syndrome in obese female patients. J Diabetes Complications 27: 346-350.
43. Wang H, Dong S, Xu H, Qian J, Yang J (2012) Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis. Mol Biol Rep 39: 5691-5698.
44. Chen B, Ye F, Yu L, Jia G, Huang X, et al. (2012) Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc 134: 17963-17971.
45. Gulati P, Yeo GS (2013) The biology of FTO: from nucleic acid demethylase to amino acid sensor. Diabetologia: [Epub ahead of print].
46. Aik W, Demetriades M, Hamdan MK, Bagg EA, Yeoh KK, et al. (2013) Structural Basis for Inhibition of the Fat Mass and Obesity Associated Protein (FTO). J Med Chem 56: 3680-3688.